Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA: 600521)
China
· Delayed Price · Currency is CNY 17.93
+0.38 (2.17%)
Nov 20, 2024, 3:00 PM CST
Zhejiang Huahai Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 9,289 | 8,249 | 8,183 | 6,603 | 6,456 | 5,361 | Upgrade
|
| Other Revenue | 59.54 | 59.54 | 82.56 | 40.95 | 29.5 | 27.36 | Upgrade
|
| Revenue | 9,349 | 8,309 | 8,266 | 6,644 | 6,485 | 5,388 | Upgrade
|
| Revenue Growth (YoY) | 8.26% | 0.52% | 24.42% | 2.44% | 20.36% | 5.76% | Upgrade
|
| Cost of Revenue | 3,535 | 3,376 | 3,180 | 2,671 | 2,385 | 2,203 | Upgrade
|
| Gross Profit | 5,814 | 4,933 | 5,086 | 3,973 | 4,100 | 3,185 | Upgrade
|
| Selling, General & Admin | 3,051 | 2,592 | 2,534 | 2,448 | 2,080 | 1,856 | Upgrade
|
| Research & Development | 1,003 | 982.99 | 925.53 | 942.26 | 565.7 | 467.36 | Upgrade
|
| Other Operating Expenses | -19.79 | 3.24 | 3.63 | 65.21 | 50.13 | 43.85 | Upgrade
|
| Operating Expenses | 4,036 | 3,570 | 3,508 | 3,470 | 2,725 | 2,357 | Upgrade
|
| Operating Income | 1,778 | 1,363 | 1,578 | 502.48 | 1,375 | 828.28 | Upgrade
|
| Interest Expense | -218.43 | -231.69 | -220.02 | -166.34 | -135.33 | -224.66 | Upgrade
|
| Interest & Investment Income | 52.47 | 39.48 | 25.83 | 180.61 | 19.57 | 20.8 | Upgrade
|
| Currency Exchange Gain (Loss) | 60.1 | 60.1 | 208.94 | -50.99 | -145.37 | 33.88 | Upgrade
|
| Other Non Operating Income (Expenses) | -74.77 | -5.14 | -3.91 | -4.32 | -3.86 | -10.33 | Upgrade
|
| EBT Excluding Unusual Items | 1,597 | 1,225 | 1,589 | 461.44 | 1,110 | 647.98 | Upgrade
|
| Impairment of Goodwill | -6.46 | -6.46 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -97.37 | -162.9 | -70 | 299.81 | 26.09 | -17.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | -9.71 | -10.28 | -16.1 | -9.59 | 19.15 | 0.02 | Upgrade
|
| Asset Writedown | -57.67 | -22.96 | -2 | -0.16 | -13.58 | -16.83 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -5.2 | Upgrade
|
| Other Unusual Items | 77.47 | 77.47 | 8.23 | 35.42 | 73.68 | 152.73 | Upgrade
|
| Pretax Income | 1,504 | 1,100 | 1,509 | 786.93 | 1,215 | 760.86 | Upgrade
|
| Income Tax Expense | 362.3 | 283.07 | 332.89 | 306.28 | 220.76 | 154.04 | Upgrade
|
| Earnings From Continuing Operations | 1,141 | 817.25 | 1,176 | 480.64 | 994.6 | 606.83 | Upgrade
|
| Minority Interest in Earnings | -1.14 | 13.22 | -8.25 | 6.89 | -64.78 | -37.23 | Upgrade
|
| Net Income | 1,140 | 830.47 | 1,168 | 487.54 | 929.82 | 569.6 | Upgrade
|
| Net Income to Common | 1,140 | 830.47 | 1,168 | 487.54 | 929.82 | 569.6 | Upgrade
|
| Net Income Growth | 4.15% | -28.88% | 139.52% | -47.57% | 63.24% | 429.78% | Upgrade
|
| Shares Outstanding (Basic) | 1,456 | 1,449 | 1,442 | 1,434 | 1,453 | 1,389 | Upgrade
|
| Shares Outstanding (Diluted) | 1,456 | 1,449 | 1,460 | 1,434 | 1,453 | 1,389 | Upgrade
|
| Shares Change (YoY) | -0.16% | -0.72% | 1.80% | -1.30% | 4.58% | 5.70% | Upgrade
|
| EPS (Basic) | 0.78 | 0.57 | 0.81 | 0.34 | 0.64 | 0.41 | Upgrade
|
| EPS (Diluted) | 0.78 | 0.57 | 0.80 | 0.34 | 0.64 | 0.41 | Upgrade
|
| EPS Growth | 3.91% | -28.75% | 135.29% | -46.88% | 56.10% | 401.22% | Upgrade
|
| Free Cash Flow | 1,171 | 624.63 | -1,074 | -1,496 | 278.97 | 959.64 | Upgrade
|
| Free Cash Flow Per Share | 0.80 | 0.43 | -0.74 | -1.04 | 0.19 | 0.69 | Upgrade
|
| Dividend Per Share | 0.200 | 0.200 | 0.240 | 0.100 | 0.200 | 0.182 | Upgrade
|
| Dividend Growth | -16.67% | -16.67% | 140.00% | -50.00% | 10.01% | - | Upgrade
|
| Gross Margin | 62.19% | 59.37% | 61.53% | 59.80% | 63.23% | 59.11% | Upgrade
|
| Operating Margin | 19.02% | 16.40% | 19.09% | 7.56% | 21.20% | 15.37% | Upgrade
|
| Profit Margin | 12.20% | 10.00% | 14.13% | 7.34% | 14.34% | 10.57% | Upgrade
|
| Free Cash Flow Margin | 12.53% | 7.52% | -12.99% | -22.52% | 4.30% | 17.81% | Upgrade
|
| EBITDA | 2,599 | 2,112 | 2,230 | 1,050 | 1,846 | 1,239 | Upgrade
|
| EBITDA Margin | 27.80% | 25.42% | 26.98% | 15.81% | 28.46% | 22.99% | Upgrade
|
| D&A For EBITDA | 821.45 | 749.07 | 652.55 | 547.8 | 470.83 | 410.66 | Upgrade
|
| EBIT | 1,778 | 1,363 | 1,578 | 502.48 | 1,375 | 828.28 | Upgrade
|
| EBIT Margin | 19.02% | 16.40% | 19.09% | 7.56% | 21.20% | 15.37% | Upgrade
|
| Effective Tax Rate | 24.09% | 25.73% | 22.06% | 38.92% | 18.16% | 20.25% | Upgrade
|
| Revenue as Reported | 9,349 | 8,309 | 8,266 | 6,644 | 6,485 | 5,388 | Upgrade
|
| Advertising Expenses | - | 1,036 | 1,034 | 999.39 | 783.51 | 676.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.